Legal & General Group Plc - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-95.5%
1,934
-25.1%
0.00%
Q1 2022$22,000
-45.0%
2,581
+4.6%
0.00%
Q4 2021$40,000
-11.1%
2,4670.0%0.00%
Q3 2021$45,000
+25.0%
2,467
-3.6%
0.00%
Q2 2021$36,000
+12.5%
2,559
+18.0%
0.00%
Q1 2021$32,000
-84.2%
2,169
-79.1%
0.00%
Q4 2020$202,000
+83.6%
10,400
+5.9%
0.00%
Q3 2020$110,000
-22.5%
9,825
-6.7%
0.00%
Q2 2020$142,000
+992.3%
10,525
+530.6%
0.00%
Q1 2020$13,000
-35.0%
1,669
-21.4%
0.00%
Q4 2019$20,000
-13.0%
2,1240.0%0.00%
Q3 2019$23,000
+35.3%
2,124
+44.1%
0.00%
Q2 2019$17,000
-10.5%
1,4740.0%0.00%
Q1 2019$19,000
+216.7%
1,474
+44.7%
0.00%
Q4 2018$6,000
-45.5%
1,0190.0%0.00%
Q3 2018$11,000
-26.7%
1,0190.0%0.00%
Q2 2018$15,000
+7.1%
1,0190.0%0.00%
Q1 2018$14,000
+16.7%
1,0190.0%0.00%
Q4 2017$12,0001,0190.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,353,303$1,637,49713.93%
Anson Funds Management LP 4,159,572$5,033,0821.01%
OUP Management Co., LLC 249,070$301,3750.68%
Atlas Venture Life Science Advisors, LLC 1,013,438$1,226,2600.19%
Murchinson Ltd. 862,700$1,043,8670.13%
Alphabet Inc. 889,979$1,076,8740.07%
AWM Investment Company, Inc. 333,400$403,4140.06%
DAFNA Capital Management LLC 125,000$151,2500.05%
Novo Holdings A/S 468,902$567,3710.04%
XTX Topco Ltd 58,368$70,6250.01%
View complete list of SPERO THERAPEUTICS INC shareholders